Expertise in
16
conditions

Berten P. Ceulemans

Edegem, VLG, BE 
Expertise in
16
conditions
Edegem, VLG, BE 

Overview

Berten Ceulemans practices practicing medicine in Edegem, Belgium.

Mr. Ceulemans is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Myoclonic Epilepsy, Dravet Syndrome, Epilepsy with Myoclonic-Atonic Seizures, and Epilepsy.

He is actively involved in clinical research, co-authoring 118 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Edegem, VLG, Belgium
Other Locations
Antwerpen, VLG 2650, Belgium
Brussels, BRU, Belgium
Wilrijk, VLG, Belgium
Pulderbos, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Enrollment Status: Completed
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
Enrollment Status: Terminated
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Controlled, Double-blind, Crossover Trial of Ganaxolone in Children With Fragile X Syndrome
A Controlled, Double-blind, Crossover Trial of Ganaxolone in Children With Fragile X Syndrome
Enrollment Status: Completed
Publish Date: April 10, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

118 Total Publications

Cerebral, spinal, ophthalmological and skeletal findings associated with abusive and non-abusive head injury in children under 2 years old: A systematic review.
Cerebral, spinal, ophthalmological and skeletal findings associated with abusive and non-abusive head injury in children under 2 years old: A systematic review.
Journal: Child abuse & neglect
Published: April 22, 2026

Frequently Asked Questions about Berten P. Ceulemans

Is Berten P. Ceulemans a top-rated expert for Myoclonic Epilepsy?

MediFind is an objective health platform that identifies experts based on real-world data. Berten P. Ceulemans is classified as an Elite expert for Myoclonic Epilepsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Berten P. Ceulemans participate in research or clinical trials?

Yes. Berten P. Ceulemans has published 118 articles and abstracts on conditions like Myoclonic Epilepsy. You can view a list of Berten P. Ceulemans's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ceulemans's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 36 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile